Rani Therapeutics is a clinical-stage biopharmaceutical company developing an oral capsule technology designed to deliver injectable medications such as proteins, peptides, antibodies, and oligonucleotides through the mouth instead of injections. The company's RaniPill platform is being tested with multiple drug candidates in its pipeline, including treatments for rheumatoid arthritis, obesity, rare diseases, and inflammatory conditions, along with a biosimilar program. Rani has established partnerships with several pharmaceutical companies to jointly develop and commercialize products using its delivery technology.
1Y: 0.59 (-73.2%) · range 0.59–2.50
entry readiness 85 · STRONG SETUP · exit proximity 0
Value area 0.72–0.96 · 99% of 120d volume overhead · heavy supply
No source detections in the last 21 days.
Not yet labeled — the study prices these as positions mature.